25 XP   0   0   10

Predictive Oncology Inc
Buy, Hold or Sell?

Let's analyse Predictive Oncology Inc together

PenkeI guess you are interested in Predictive Oncology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Predictive Oncology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Predictive Oncology Inc

I send you an email if I find something interesting about Predictive Oncology Inc.

Quick analysis of Predictive Oncology Inc (30 sec.)










What can you expect buying and holding a share of Predictive Oncology Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$2.04
Expected worth in 1 year
$-1.29
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-3.32
Return On Investment
-247.8%

For what price can you sell your share?

Current Price per Share
$1.34
Expected price per share
$0 - $2.756
How sure are you?
50%

1. Valuation of Predictive Oncology Inc (5 min.)




Live pricePrice per Share (EOD)

$1.34

Intrinsic Value Per Share

$-49.59 - $-26.84

Total Value Per Share

$-47.55 - $-24.80

2. Growth of Predictive Oncology Inc (5 min.)




Is Predictive Oncology Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$8.2m$30.5m-$17.2m-129.5%

How much money is Predictive Oncology Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.7m-$11.7m$8m217.6%
Net Profit Margin-1,013.7%-3,190.5%--

How much money comes from the company's main activities?

3. Financial Health of Predictive Oncology Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#141 / 169

Most Revenue
#151 / 169

Most Profit
#130 / 169

Most Efficient
#158 / 169

What can you expect buying and holding a share of Predictive Oncology Inc? (5 min.)

Welcome investor! Predictive Oncology Inc's management wants to use your money to grow the business. In return you get a share of Predictive Oncology Inc.

What can you expect buying and holding a share of Predictive Oncology Inc?

First you should know what it really means to hold a share of Predictive Oncology Inc. And how you can make/lose money.

Speculation

The Price per Share of Predictive Oncology Inc is $1.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Predictive Oncology Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Predictive Oncology Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.04. Based on the TTM, the Book Value Change Per Share is $-0.83 per quarter. Based on the YOY, the Book Value Change Per Share is $1.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Predictive Oncology Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.86-63.8%-0.89-66.5%-1.58-118.2%-1.07-80.2%-0.78-58.1%
Usd Book Value Change Per Share-0.83-62.1%-0.83-62.0%1.1988.5%0.107.5%0.075.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%9.89737.9%4.94369.0%
Usd Total Gains Per Share-0.83-62.1%-0.83-62.0%1.1988.5%9.99745.5%5.01374.2%
Usd Price Per Share3.29-2.92-0.51-1.40-1.52-
Price to Earnings Ratio-0.96--0.83--0.12--0.41--0.73-
Price-to-Total Gains Ratio-3.96--3.44--0.22--0.47--1.34-
Price to Book Ratio1.62-1.04-0.07-3.52-4.91-
Price-to-Total Gains Ratio-3.96--3.44--0.22--0.47--1.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.34
Number of shares746
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.009.89
Usd Book Value Change Per Share-0.830.10
Usd Total Gains Per Share-0.839.99
Gains per Quarter (746 shares)-619.367,452.00
Gains per Year (746 shares)-2,477.4329,808.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2478-24872950630229798
20-4955-49645901260459606
30-7433-74418851990589414
41-9910-99181180251207119222
51-12388-123951475311509149030
61-14865-148721770371811178838
71-17343-173492065442112208646
81-19821-198262360502414238454
91-22298-223032655562716268262
101-24776-247802950623018298070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.060.00.01.6%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.012.02.030.0%12.024.04.030.0%17.037.07.027.9%
Dividend per Share1.00.03.025.0%2.00.010.016.7%3.00.017.015.0%3.00.037.07.5%3.00.058.04.9%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%7.011.02.035.0%13.023.04.032.5%18.036.07.029.5%

Fundamentals of Predictive Oncology Inc

About Predictive Oncology Inc

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

Fundamental data was last updated by Penke on 2024-04-12 15:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Predictive Oncology Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Predictive Oncology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -1,037.3% means that $-10.37 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Predictive Oncology Inc:

  • The MRQ is -1,037.3%. The company is making a huge loss. -2
  • The TTM is -1,013.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,037.3%TTM-1,013.7%-23.6%
TTM-1,013.7%YOY-3,190.5%+2,176.8%
TTM-1,013.7%5Y-1,931.8%+918.1%
5Y-1,931.8%10Y-1,578.6%-353.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,037.3%6.2%-1,043.5%
TTM-1,013.7%6.4%-1,020.1%
YOY-3,190.5%8.0%-3,198.5%
5Y-1,931.8%7.3%-1,939.1%
10Y-1,578.6%6.8%-1,585.4%
1.1.2. Return on Assets

Shows how efficient Predictive Oncology Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • -24.1% Return on Assets means that Predictive Oncology Inc generated $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Predictive Oncology Inc:

  • The MRQ is -24.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-19.3%-4.8%
TTM-19.3%YOY-38.7%+19.4%
TTM-19.3%5Y-31.1%+11.8%
5Y-31.1%10Y-62.0%+30.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%1.3%-25.4%
TTM-19.3%1.4%-20.7%
YOY-38.7%1.9%-40.6%
5Y-31.1%2.1%-33.2%
10Y-62.0%2.0%-64.0%
1.1.3. Return on Equity

Shows how efficient Predictive Oncology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • -42.0% Return on Equity means Predictive Oncology Inc generated $-0.42 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Predictive Oncology Inc:

  • The MRQ is -42.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.0%TTM-29.7%-12.3%
TTM-29.7%YOY-44.2%+14.5%
TTM-29.7%5Y-377.9%+348.2%
5Y-377.9%10Y-609.4%+231.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.0%2.6%-44.6%
TTM-29.7%2.8%-32.5%
YOY-44.2%3.7%-47.9%
5Y-377.9%3.9%-381.8%
10Y-609.4%3.9%-613.3%

1.2. Operating Efficiency of Predictive Oncology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Predictive Oncology Inc is operating .

  • Measures how much profit Predictive Oncology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -1,046.4% means the company generated $-10.46  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Predictive Oncology Inc:

  • The MRQ is -1,046.4%. The company is operating very inefficient. -2
  • The TTM is -918.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,046.4%TTM-918.8%-127.6%
TTM-918.8%YOY-544.0%-374.8%
TTM-918.8%5Y-650.4%-268.4%
5Y-650.4%10Y-910.8%+260.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,046.4%7.9%-1,054.3%
TTM-918.8%7.6%-926.4%
YOY-544.0%10.9%-554.9%
5Y-650.4%10.1%-660.5%
10Y-910.8%10.5%-921.3%
1.2.2. Operating Ratio

Measures how efficient Predictive Oncology Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 11.46 means that the operating costs are $11.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Predictive Oncology Inc:

  • The MRQ is 11.464. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.266. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.464TTM10.266+1.198
TTM10.266YOY11.241-0.975
TTM10.2665Y11.100-0.833
5Y11.10010Y11.901-0.801
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4641.152+10.312
TTM10.2661.146+9.120
YOY11.2411.082+10.159
5Y11.1001.097+10.003
10Y11.9011.056+10.845

1.3. Liquidity of Predictive Oncology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Predictive Oncology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.55 means the company has $2.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Predictive Oncology Inc:

  • The MRQ is 2.551. The company is able to pay all its short-term debts. +1
  • The TTM is 3.773. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.551TTM3.773-1.223
TTM3.773YOY8.526-4.753
TTM3.7735Y4.851-1.078
5Y4.85110Y3.297+1.554
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5512.310+0.241
TTM3.7732.339+1.434
YOY8.5262.575+5.951
5Y4.8512.627+2.224
10Y3.2972.623+0.674
1.3.2. Quick Ratio

Measures if Predictive Oncology Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 2.29 means the company can pay off $2.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Predictive Oncology Inc:

  • The MRQ is 2.294. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.536. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.294TTM3.536-1.243
TTM3.536YOY8.192-4.656
TTM3.5365Y4.666-1.129
5Y4.66610Y2.928+1.738
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2941.105+1.189
TTM3.5361.137+2.399
YOY8.1921.306+6.886
5Y4.6661.430+3.236
10Y2.9281.533+1.395

1.4. Solvency of Predictive Oncology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Predictive Oncology Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Predictive Oncology Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.43 means that Predictive Oncology Inc assets are financed with 42.6% credit (debt) and the remaining percentage (100% - 42.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Predictive Oncology Inc:

  • The MRQ is 0.426. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.336. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.426TTM0.336+0.090
TTM0.336YOY0.104+0.232
TTM0.3365Y0.330+0.006
5Y0.33010Y1.188-0.858
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4260.357+0.069
TTM0.3360.360-0.024
YOY0.1040.358-0.254
5Y0.3300.365-0.035
10Y1.1880.375+0.813
1.4.2. Debt to Equity Ratio

Measures if Predictive Oncology Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 74.3% means that company has $0.74 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Predictive Oncology Inc:

  • The MRQ is 0.743. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.520. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.743TTM0.520+0.223
TTM0.520YOY0.117+0.402
TTM0.5205Y4.029-3.509
5Y4.02910Y8.117-4.088
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7430.541+0.202
TTM0.5200.561-0.041
YOY0.1170.561-0.444
5Y4.0290.648+3.381
10Y8.1170.669+7.448

2. Market Valuation of Predictive Oncology Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Predictive Oncology Inc generates.

  • Above 15 is considered overpriced but always compare Predictive Oncology Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.96 means the investor is paying $-0.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Predictive Oncology Inc:

  • The EOD is -0.392. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.962. Based on the earnings, the company is expensive. -2
  • The TTM is -0.833. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.392MRQ-0.962+0.570
MRQ-0.962TTM-0.833-0.129
TTM-0.833YOY-0.116-0.717
TTM-0.8335Y-0.410-0.423
5Y-0.41010Y-0.734+0.324
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.39214.579-14.971
MRQ-0.96216.584-17.546
TTM-0.83317.443-18.276
YOY-0.11622.147-22.263
5Y-0.41020.830-21.240
10Y-0.73425.069-25.803
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Predictive Oncology Inc:

  • The EOD is -0.443. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.087. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.879. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.443MRQ-1.087+0.644
MRQ-1.087TTM-0.879-0.208
TTM-0.879YOY-0.163-0.716
TTM-0.8795Y-0.715-0.164
5Y-0.71510Y-2.185+1.469
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4439.822-10.265
MRQ-1.08710.068-11.155
TTM-0.8791.387-2.266
YOY-0.1633.453-3.616
5Y-0.7155.897-6.612
10Y-2.185-0.177-2.008
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Predictive Oncology Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.62 means the investor is paying $1.62 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Predictive Oncology Inc:

  • The EOD is 0.658. Based on the equity, the company is cheap. +2
  • The MRQ is 1.616. Based on the equity, the company is underpriced. +1
  • The TTM is 1.037. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.658MRQ1.616-0.958
MRQ1.616TTM1.037+0.579
TTM1.037YOY0.066+0.971
TTM1.0375Y3.517-2.481
5Y3.51710Y4.914-1.397
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.6582.398-1.740
MRQ1.6162.753-1.137
TTM1.0372.690-1.653
YOY0.0663.294-3.228
5Y3.5173.563-0.046
10Y4.9144.227+0.687
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Predictive Oncology Inc.

3.1. Institutions holding Predictive Oncology Inc

Institutions are holding 9.088% of the shares of Predictive Oncology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc3.4605014060400
2023-09-30Raymond James & Associates2.90980.00031182291182290
2023-09-30Geode Capital Management, LLC0.9223037472516815.998
2023-12-31Rb Capital Management, LLC0.51280.01962083500
2023-09-30State Street Corporation0.4144016837460037.5909
2023-12-31Renaissance Technologies Corp0.34890.000114176-2700-15.9991
2023-09-30Susquehanna International Group, LLP0.3019012265122650
2023-09-30UBS Group AG0.060802469-1439-36.8219
2023-09-30Advisor Group Holdings, Inc.0.037501525-200-11.5942
2023-09-30Tower Research Capital LLC0.01710.00016946940
2023-09-30PSI Advisors, LLC0.00980.000639900
2023-09-30Wells Fargo & Co0.00810329258.2237
2023-09-30BlackRock Inc0.0037015200
2023-09-30JPMorgan Chase & Co0.000105-434-98.861
2023-09-30CWM, LLC duplicate0.00010500
2023-09-30Cornerstone Planning Group LLC00110
Total 9.00780.0207365997+136209+37.2%

3.2. Funds holding Predictive Oncology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.77720722114120.5738
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.71990.00026988100
2024-01-31Fidelity Extended Market Index0.52590.00022136900
2024-01-31Fidelity Nasdaq Composite Index0.16150.0001656100
2023-12-31SSgA U.S. Extended Market Index Class I0.11680.0006474700
2024-01-31Fidelity Series Total Market Index0.1140463298026.8346
2024-01-31Fidelity Total Market Index0.09310378200
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08610.0002350000
2023-12-31Northern Trust Extended Eq Market Idx0.08610.0002350000
2024-02-29Dimensional US Core Equity 2 ETF0.05070205800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04430.0001180000
2024-02-29State St US Extended Mkt Indx NL Cl C0.0430.00031747-3000-63.1978
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03560.0001144630.2079
2024-02-29Vanguard U.S. Eq Idx £ Acc0.03510142600
2023-12-31SSgA U.S. Total Market Index Strategy0.03370.00011369-32-2.2841
2024-01-31Spartan Total Market Index Pool E0.03240131800
2024-01-31Spartan Extended Market Index Pool E0.01890.000176600
2024-01-31DFA US Core Equity 2 I0.0152061700
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0092037500
2023-09-30BlackRock Extended Mkt Composite0.0037015100
Total 5.00240.0022203256-1637-0.8%

3.3. Insider Transactions

Insiders are holding 3.136% of the shares of Predictive Oncology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-25Charles Lee Sr Nuzum SrSELL100003.04

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Predictive Oncology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.832-0.8300%1.185-170%0.101-922%0.071-1277%
Book Value Per Share--2.0363.272-38%7.511-73%4.930-59%2.524-19%
Current Ratio--2.5513.773-32%8.526-70%4.851-47%3.297-23%
Debt To Asset Ratio--0.4260.336+27%0.104+311%0.330+29%1.188-64%
Debt To Equity Ratio--0.7430.520+43%0.117+534%4.029-82%8.117-91%
Dividend Per Share---0.000-100%-0%9.888-100%4.944-100%
Eps---0.855-0.891+4%-1.584+85%-1.075+26%-0.779-9%
Free Cash Flow Per Share---0.757-0.830+10%-0.790+4%-0.657-13%-0.485-36%
Free Cash Flow To Equity Per Share---0.784-0.820+5%-0.377-52%0.248-416%0.137-671%
Gross Profit Margin--1.1081.103+0%1.053+5%1.036+7%1.089+2%
Intrinsic Value_10Y_max---26.835--------
Intrinsic Value_10Y_min---49.589--------
Intrinsic Value_1Y_max---2.050--------
Intrinsic Value_1Y_min---3.304--------
Intrinsic Value_3Y_max---6.646--------
Intrinsic Value_3Y_min---11.429--------
Intrinsic Value_5Y_max---11.830--------
Intrinsic Value_5Y_min---21.136--------
Market Cap5444527.200-146%13367533.20011861146.290+13%2086391.580+541%9158707.915+46%7919510.448+69%
Net Profit Margin---10.373-10.137-2%-31.905+208%-19.318+86%-15.786+52%
Operating Margin---10.464-9.188-12%-5.440-48%-6.504-38%-9.108-13%
Operating Ratio--11.46410.266+12%11.241+2%11.100+3%11.901-4%
Pb Ratio0.658-146%1.6161.037+56%0.066+2356%3.517-54%4.914-67%
Pe Ratio-0.392+59%-0.962-0.833-13%-0.116-88%-0.410-57%-0.734-24%
Price Per Share1.340-146%3.2902.919+13%0.514+541%1.395+136%1.520+116%
Price To Free Cash Flow Ratio-0.443+59%-1.087-0.879-19%-0.163-85%-0.715-34%-2.185+101%
Price To Total Gains Ratio-1.611+59%-3.955-3.439-13%-0.218-94%-0.469-88%-1.335-66%
Quick Ratio--2.2943.536-35%8.192-72%4.666-51%2.928-22%
Return On Assets---0.241-0.193-20%-0.387+60%-0.311+29%-0.620+157%
Return On Equity---0.420-0.297-29%-0.442+5%-3.779+799%-6.094+1350%
Total Gains Per Share---0.832-0.8300%1.185-170%9.989-108%5.015-117%
Usd Book Value--8271780.00013295644.250-38%30518665.250-73%22201648.250-63%11340236.350-27%
Usd Book Value Change Per Share---0.832-0.8300%1.185-170%0.101-922%0.071-1277%
Usd Book Value Per Share--2.0363.272-38%7.511-73%4.930-59%2.524-19%
Usd Dividend Per Share---0.000-100%-0%9.888-100%4.944-100%
Usd Eps---0.855-0.891+4%-1.584+85%-1.075+26%-0.779-9%
Usd Free Cash Flow---3075065.000-3372940.250+10%-3211624.250+4%-2993330.400-3%-2130004.050-31%
Usd Free Cash Flow Per Share---0.757-0.830+10%-0.790+4%-0.657-13%-0.485-36%
Usd Free Cash Flow To Equity Per Share---0.784-0.820+5%-0.377-52%0.248-416%0.137-671%
Usd Market Cap5444527.200-146%13367533.20011861146.290+13%2086391.580+541%9158707.915+46%7919510.448+69%
Usd Price Per Share1.340-146%3.2902.919+13%0.514+541%1.395+136%1.520+116%
Usd Profit---3475347.000-3704826.000+7%-11764909.250+239%-6799456.350+96%-4380525.250+26%
Usd Revenue--335032.000445023.250-25%376364.750-11%373945.450-10%285776.200+17%
Usd Total Gains Per Share---0.832-0.8300%1.185-170%9.989-108%5.015-117%
 EOD+3 -5MRQTTM+14 -22YOY+15 -195Y+14 -2210Y+14 -22

4.2. Fundamental Score

Let's check the fundamental score of Predictive Oncology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.392
Price to Book Ratio (EOD)Between0-10.658
Net Profit Margin (MRQ)Greater than0-10.373
Operating Margin (MRQ)Greater than0-10.464
Quick Ratio (MRQ)Greater than12.294
Current Ratio (MRQ)Greater than12.551
Debt to Asset Ratio (MRQ)Less than10.426
Debt to Equity Ratio (MRQ)Less than10.743
Return on Equity (MRQ)Greater than0.15-0.420
Return on Assets (MRQ)Greater than0.05-0.241
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Predictive Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.668
Ma 20Greater thanMa 501.738
Ma 50Greater thanMa 1002.479
Ma 100Greater thanMa 2002.785
OpenGreater thanClose1.290
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  210-90120211330278608-679-71



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets14,417
Total Liabilities6,145
Total Stockholder Equity8,272
 As reported
Total Liabilities 6,145
Total Stockholder Equity+ 8,272
Total Assets = 14,417

Assets

Total Assets14,417
Total Current Assets10,078
Long-term Assets4,339
Total Current Assets
Cash And Cash Equivalents 8,729
Net Receivables 334
Inventory 494
Other Current Assets 522
Total Current Assets  (as reported)10,078
Total Current Assets  (calculated)10,078
+/-0
Long-term Assets
Property Plant Equipment 3,962
Intangible Assets 248
Long-term Assets Other 128
Long-term Assets  (as reported)4,339
Long-term Assets  (calculated)4,339
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,951
Long-term Liabilities2,194
Total Stockholder Equity8,272
Total Current Liabilities
Short-term Debt 668
Short Long Term Debt 150
Accounts payable 1,342
Other Current Liabilities 1,633
Total Current Liabilities  (as reported)3,951
Total Current Liabilities  (calculated)3,793
+/- 158
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,039
Long-term Liabilities Other 5
Long-term Liabilities  (as reported)2,194
Long-term Liabilities  (calculated)2,044
+/- 150
Total Stockholder Equity
Common Stock41
Retained Earnings -167,762
Accumulated Other Comprehensive Income -41
Other Stockholders Equity 176,033
Total Stockholder Equity (as reported)8,272
Total Stockholder Equity (calculated)8,271
+/- 1
Other
Capital Stock41
Cash and Short Term Investments 8,729
Common Stock Shares Outstanding 4,063
Current Deferred Revenue308
Liabilities and Stockholders Equity 14,417
Net Debt -5,872
Net Invested Capital 8,421
Net Working Capital 6,127
Property Plant and Equipment Gross 7,550
Short Long Term Debt Total 2,857



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-30
> Total Assets 
0
789
0
0
410
290
263
204
180
166
485
251
274
446
446
375
444
370
811
444
637
593
997
973
1,237
901
901
745
8,416
5,632
4,051
2,895
1,917
2,808
5,466
4,532
3,499
3,624
3,624
4,001
5,416
3,709
3,709
32,252
31,882
22,376
22,376
27,496
25,161
13,060
39,654
56,912
51,190
43,771
40,059
36,496
33,166
25,735
25,062
20,967
18,167
14,417
14,41718,16720,96725,06225,73533,16636,49640,05943,77151,19056,91239,65413,06025,16127,49622,37622,37631,88232,2523,7093,7095,4164,0013,6243,6243,4994,5325,4662,8081,9172,8954,0515,6328,4167459019011,237973997593637444811370444375446446274251485166180204263290410007890
   > Total Current Assets 
0
635
0
0
258
140
113
55
31
18
337
103
128
301
301
230
299
225
667
383
547
382
709
700
947
631
631
520
8,197
5,398
3,819
2,677
1,709
2,608
5,258
4,329
3,303
2,371
2,371
2,007
3,110
1,452
1,452
1,094
1,063
798
798
4,329
3,458
1,514
28,202
45,637
43,040
29,458
26,244
29,824
26,857
23,360
19,780
15,970
13,520
10,078
10,07813,52015,97019,78023,36026,85729,82426,24429,45843,04045,63728,2021,5143,4584,3297987981,0631,0941,4521,4523,1102,0072,3712,3713,3034,3295,2582,6081,7092,6773,8195,3988,197520631631947700709382547383667225299230301301128103337183155113140258006350
       Cash And Cash Equivalents 
0
464
0
0
68
17
41
9
20
9
331
58
78
123
123
35
102
13
373
137
328
102
131
40
244
16
16
44
7,733
4,856
2,536
583
634
1,764
2,086
1,160
766
766
766
1,004
210
162
162
70
99
151
151
3,394
2,474
678
27,299
44,881
41,772
28,203
25,116
28,249
25,394
22,072
18,597
14,764
11,915
8,729
8,72911,91514,76418,59722,07225,39428,24925,11628,20341,77244,88127,2996782,4743,39415115199701621622101,0047667667661,1602,0861,7646345832,5364,8567,73344161624440131102328137373131023512312378583319209411768004640
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
803
856
577
284
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000284284577856803000000000000000000000000000000
       Net Receivables 
0
0
0
0
16
16
16
0
0
0
0
1
19
50
50
32
40
40
97
102
83
97
64
150
239
58
58
16
14
38
53
24
45
39
69
45
877
805
805
483
2,217
730
730
549
622
297
297
272
508
257
265
197
275
354
265
336
325
331
283
431
545
334
3345454312833313253362653542751972652575082722972976225497307302,217483805805877456939452453381416585823915064978310297404032505019100001616160000
       Other Current Assets 
0
171
0
0
163
107
72
46
10
8
6
45
31
0
30
66
23
27
56
36
34
61
123
150
149
0
190
203
213
272
1,000
701
163
100
2,694
2,693
1,225
0
535
275
404
0
318
155
132
0
160
427
269
289
345
242
595
514
408
763
645
527
520
381
621
522
5226213815205276457634085145952423452892694271600132155318040427553501,2252,6932,6941001637011,000272213203190014915012361343656272366300314568104672107163001710
   > Long-term Assets 
0
154
0
0
151
151
150
150
149
148
148
147
147
0
145
145
144
144
144
61
90
211
289
273
290
0
270
225
219
235
232
218
208
199
208
203
196
0
1,253
1,994
2,306
0
2,257
31,158
30,819
21,577
21,577
23,168
21,703
11,546
11,452
11,275
8,150
14,313
13,814
6,672
6,309
2,375
5,281
4,997
4,646
4,339
4,3394,6464,9975,2812,3756,3096,67213,81414,3138,15011,27511,45211,54621,70323,16821,57721,57730,81931,1582,25702,3061,9941,2530196203208199208218232235219225270029027328921190611441441441451450147147148148149150150151151001540
       Property Plant Equipment 
0
12
0
0
10
9
9
8
7
7
6
6
5
5
5
4
4
4
3
12
37
158
221
205
217
196
196
147
127
140
138
121
111
101
113
110
100
88
88
184
198
180
180
2,775
2,520
2,238
2,238
3,938
5,546
5,218
5,205
5,082
4,772
3,326
2,988
2,806
2,532
2,045
4,834
4,557
4,263
3,962
3,9624,2634,5574,8342,0452,5322,8062,9883,3264,7725,0825,2055,2185,5463,9382,2382,2382,5202,77518018019818488881001101131011111211381401271471961962172052211583712344455566778991000120
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,790
23,790
15,690
15,690
15,690
12,693
2,814
2,814
2,814
0
6,858
6,858
0
0
0
0
0
0
0
00000006,8586,85802,8142,8142,81412,69315,69015,69015,69023,79023,7900000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000582000000000000000000000000000000000000000
       Intangible Assets 
0
142
0
0
142
142
142
142
142
142
142
142
142
141
141
141
141
141
141
49
52
53
68
68
73
73
73
78
92
95
95
96
97
98
95
93
97
0
95
115
973
964
964
4,592
4,508
3,649
3,649
3,540
3,464
3,398
3,316
3,255
3,199
3,962
3,893
3,791
3,702
254
273
266
259
248
2482592662732543,7023,7913,8933,9623,1993,2553,3163,3983,4643,5403,6493,6494,5084,592964964973115950979395989796959592787373736868535249141141141141141141142142142142142142142142142001420
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,113
1,135
1,113
0
0
0
0
0
0
0
1,512
116
124
179
167
76
76
76
76
0
174
0
0
001740767676761671791241161,51200000001,1131,1351,113000000000000000000000000000000000000000
> Total Liabilities 
0
1,098
0
0
2,690
2,632
2,751
2,213
2,230
2,355
2,721
2,690
2,749
3,149
3,149
2,643
2,673
3,673
3,655
3,935
1,845
3,812
2,654
4,196
5,072
6,417
6,417
6,890
2,602
1,520
1,520
2,109
1,906
1,884
1,484
1,333
1,217
932
932
639
2,389
3,656
3,656
9,960
11,168
11,144
11,144
15,805
12,924
10,418
4,109
3,824
3,405
3,506
2,878
2,960
3,573
3,969
6,507
6,262
6,516
6,145
6,1456,5166,2626,5073,9693,5732,9602,8783,5063,4053,8244,10910,41812,92415,80511,14411,14411,1689,9603,6563,6562,3896399329321,2171,3331,4841,8841,9062,1091,5201,5202,6026,8906,4176,4175,0724,1962,6543,8121,8453,9353,6553,6732,6732,6433,1493,1492,7492,6902,7212,3552,2302,2132,7512,6322,690001,0980
   > Total Current Liabilities 
0
1,000
0
0
1,535
1,444
1,647
1,374
1,577
1,334
1,780
1,919
1,956
2,353
2,353
2,447
2,496
3,414
3,008
3,386
1,385
3,469
2,348
3,906
4,842
6,203
6,203
6,890
2,602
1,520
1,520
1,554
1,473
1,574
1,297
1,255
1,217
932
932
639
2,389
3,656
3,656
9,456
10,782
10,874
10,874
14,652
11,607
9,337
3,261
3,222
2,986
3,241
2,681
2,825
3,468
3,883
3,910
3,763
4,172
3,951
3,9514,1723,7633,9103,8833,4682,8252,6813,2412,9863,2223,2619,33711,60714,65210,87410,87410,7829,4563,6563,6562,3896399329321,2171,2551,2971,5741,4731,5541,5201,5202,6026,8906,2036,2034,8423,9062,3483,4691,3853,3863,0083,4142,4962,4472,3532,3531,9561,9191,7801,3341,5771,3741,6471,4441,535001,0000
       Short-term Debt 
0
198
0
0
198
74
274
14
64
66
604
666
684
1,056
1,056
1,206
1,156
1,081
976
1,576
0
280
280
81
1,170
937
937
933
0
0
0
0
0
0
0
0
0
0
0
0
1,005
1,635
1,635
4,310
4,971
4,796
5,255
4,885
6,329
5,029
603
640
637
640
569
422
220
94
428
466
816
668
668816466428942204225696406376406035,0296,3294,8855,2554,7964,9714,3101,6351,6351,0050000000000009339379371,1708128028001,5769761,0811,1561,2061,0561,05668466660466641427474198001980
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,079
3,809
4,470
4,796
3,817
4,412
5,752
4,432
0
0
0
0
0
0
0
0
0
0
260
150
15026000000000004,4325,7524,4123,8174,7964,4703,8093,079000000000000000000000000000000000000000000
       Accounts payable 
0
497
0
0
686
814
809
1,035
1,128
769
653
732
720
0
731
663
723
734
612
661
636
1,062
1,103
1,625
1,578
0
2,195
2,474
1,139
650
792
750
648
220
79
57
75
0
140
166
409
446
446
3,539
3,762
3,156
3,156
2,449
1,629
1,372
1,027
942
1,030
1,022
1,107
984
917
943
1,424
1,013
1,168
1,342
1,3421,1681,0131,4249439179841,1071,0221,0309421,0271,3721,6292,4493,1563,1563,7623,53944644640916614007557792206487507926501,1392,4742,19501,5781,6251,1031,06263666161273472366373107207326537691,1281,035809814686004970
       Other Current Liabilities 
0
503
0
0
355
355
355
326
384
499
523
521
552
0
567
578
616
1,600
1,405
1,144
744
2,058
1,176
2,194
2,090
0
3,066
3,474
1,434
864
723
799
820
1,346
1,203
1,184
1,133
0
785
455
960
296
1,552
1,577
2,018
91
2,423
7,279
3,583
2,882
1,477
1,486
1,166
1,392
823
889
1,836
2,243
1,419
1,656
1,813
1,633
1,6331,8131,6561,4192,2431,8368898231,3921,1661,4861,4772,8823,5837,2792,423912,0181,5771,55229696045578501,1331,1841,2031,3468207997238641,4343,4743,06602,0902,1941,1762,0587441,1441,4051,6006165785670552521523499384326355355355005030
   > Long-term Liabilities 
0
98
0
0
1,155
1,188
1,103
839
653
1,022
941
771
793
0
796
196
177
258
648
549
460
343
306
290
229
0
214
0
0
0
0
555
432
310
187
77
0
0
558
455
960
0
255
504
386
270
270
1,153
1,317
1,081
848
602
419
265
197
135
105
86
2,597
2,499
2,344
2,194
2,1942,3442,4992,597861051351972654196028481,0811,3171,153270270386504255096045555800771873104325550000214022929030634346054964825817719679607937719411,0226538391,1031,1881,15500980
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,115
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,1150000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98
95
236
163
47
31
25
63
22
100
0
0
0
0
0
000001002263253147163236959800000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
-309
0
0
-2,280
-2,342
-2,488
-2,009
-2,050
-2,190
-2,236
-2,439
-2,475
0
-2,703
-2,268
-2,229
-3,303
-2,845
-3,492
-1,209
-3,218
-1,657
-3,224
-3,835
0
-5,516
-6,144
5,814
4,113
2,531
785
12
924
3,983
3,199
2,282
0
2,692
3,362
3,027
53
53
22,292
20,714
11,231
11,231
11,691
12,237
2,643
35,545
53,088
47,785
40,266
37,180
33,535
29,593
21,766
18,554
14,705
11,651
8,272
8,27211,65114,70518,55421,76629,59333,53537,18040,26647,78553,08835,5452,64312,23711,69111,23111,23120,71422,29253533,0273,3622,69202,2823,1993,983924127852,5314,1135,814-6,144-5,5160-3,835-3,224-1,657-3,218-1,209-3,492-2,845-3,303-2,229-2,268-2,7030-2,475-2,439-2,236-2,190-2,050-2,009-2,488-2,342-2,28000-3090
   Common Stock
0
81
0
0
104
114
119
128
136
140
214
236
291
0
321
673
986
1,042
1,203
1,220
2,196
2,199
2,222
2,229
30
0
31
33
52
52
533
777
34
46
65
62
62
0
69
121
134
141
141
310
31
41
41
132
166
198
488
653
655
656
659
782
784
788
40
40
40
41
414040407887847826596566556534881981661324141313101411411341216906262654634777533525233310302,2292,2222,1992,1961,2201,2031,042986673321029123621414013612811911410400810
   Retained Earnings Total Equity0000000000-114,846-112,272-108,3830000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-17
-26
-43
-61
-79
-79
-111
-125
-144
3
6
5
2
-231
-245
-260
-274
-274
-307
-333
-359
-359
-512
-69,000
-772
-772
-879
-1,115
108,383
0
0
0
-1
0
0
0
0
0
-1
-1
-41
-41-1-100000-1000108,383-1,115-879-772-772-69,000-512-359-359-333-307-274-274-260-245-2312563-144-125-111-79-79-61-43-26-17000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,297
63,020
66,297
86,882
89,591
93,654
97,289
0
0
110,827
147,328
167,280
0
0
0
0
0
0
0
0
0
0
0000000000167,280147,328110,8270097,28993,65489,59186,88266,29763,02064,2970000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,753
0
0
3,269
3,574
4,174
4,691
4,800
5,052
5,410
5,572
6,135
0
8,845
11,777
14,359
14,945
17,345
17,857
23,138
23,296
26,480
26,690
29,441
0
30,173
31,046
44,098
44,678
44,658
45,232
46,258
47,894
52,508
54,286
54,374
0
57,654
62,446
64,630
0
63,378
87,394
158,591
0
94,425
103,043
110,098
2,444
147,328
167,280
167,413
167,650
167,932
174,555
174,670
174,755
175,713
175,788
175,898
176,033
176,033175,898175,788175,713174,755174,670174,555167,932167,650167,413167,280147,3282,444110,098103,04394,4250158,59187,39463,378064,63062,44657,654054,37454,28652,50847,89446,25845,23244,65844,67844,09831,04630,173029,44126,69026,48023,29623,13817,85717,34514,94514,35911,7778,84506,1355,5725,4105,0524,8004,6914,1743,5743,269002,7530



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,780
Cost of Revenue-1,347
Gross Profit433433
 
Operating Income (+$)
Gross Profit433
Operating Expense-14,355
Operating Income-13,921-13,921
 
Operating Expense (+$)
Research Development188
Selling General Administrative9,428
Selling And Marketing Expenses1,511
Operating Expense14,35511,128
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-13,921
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-13,984-13,859
EBIT - interestExpense = -13,921
-13,984
-13,984
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-13,921-13,984
Earnings Before Interest and Taxes (EBITDA)-13,182
 
After tax Income (+$)
Income Before Tax-13,984
Tax Provision-0
Net Income From Continuing Ops-18,425-13,984
Net Income-13,984
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,701
Total Other Income/Expenses Net-630
 

Technical Analysis of Predictive Oncology Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Predictive Oncology Inc. The general trend of Predictive Oncology Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Predictive Oncology Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Predictive Oncology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.47 < 2.51 < 2.756.

The bearish price targets are: .

Tweet this
Predictive Oncology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Predictive Oncology Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Predictive Oncology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Predictive Oncology Inc. The current macd is -0.36958457.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Predictive Oncology Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Predictive Oncology Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Predictive Oncology Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Predictive Oncology Inc Daily Moving Average Convergence/Divergence (MACD) ChartPredictive Oncology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Predictive Oncology Inc. The current adx is 35.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Predictive Oncology Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Predictive Oncology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Predictive Oncology Inc. The current sar is 1.48129604.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Predictive Oncology Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Predictive Oncology Inc. The current rsi is 26.67. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Predictive Oncology Inc Daily Relative Strength Index (RSI) ChartPredictive Oncology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Predictive Oncology Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Predictive Oncology Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Predictive Oncology Inc Daily Stochastic Oscillator ChartPredictive Oncology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Predictive Oncology Inc. The current cci is -81.6965066.

Predictive Oncology Inc Daily Commodity Channel Index (CCI) ChartPredictive Oncology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Predictive Oncology Inc. The current cmo is -40.99387697.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Predictive Oncology Inc Daily Chande Momentum Oscillator (CMO) ChartPredictive Oncology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Predictive Oncology Inc. The current willr is -77.31958763.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Predictive Oncology Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Predictive Oncology Inc Daily Williams %R ChartPredictive Oncology Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Predictive Oncology Inc.

Predictive Oncology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Predictive Oncology Inc. The current atr is 0.2040547.

Predictive Oncology Inc Daily Average True Range (ATR) ChartPredictive Oncology Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Predictive Oncology Inc. The current obv is -4,845,539.

Predictive Oncology Inc Daily On-Balance Volume (OBV) ChartPredictive Oncology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Predictive Oncology Inc. The current mfi is 22.41.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Predictive Oncology Inc Daily Money Flow Index (MFI) ChartPredictive Oncology Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Predictive Oncology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Predictive Oncology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Predictive Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.668
Ma 20Greater thanMa 501.738
Ma 50Greater thanMa 1002.479
Ma 100Greater thanMa 2002.785
OpenGreater thanClose1.290
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Predictive Oncology Inc with someone you think should read this too:
  • Are you bullish or bearish on Predictive Oncology Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Predictive Oncology Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Predictive Oncology Inc

I send you an email if I find something interesting about Predictive Oncology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Predictive Oncology Inc.

Receive notifications about Predictive Oncology Inc in your mailbox!